Very recently, we were able to demonstrate in vivo, that CK2α is frequently overexpressed in CRCs and that a high nuclear/cytoplasmic expression of CK2α is responsible for enhanced phosphorylation of MLH1 and increased tumor mutation rates in these tumors15. This evidence concerns the gene MLH1 and neoplasm.